WHO ICTRP trial
The effect of intralipid in recurrent implantation failure
IRCT20221016056198N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20221016056198N2 |
|---|---|
| Public title | The effect of intralipid in recurrent implantation failure |
| Scientific title | The effect of intravenous intralipid administration on reproductive outcomes for couples with recurrent implantation failure in non-donor in vitro fertilization /intracytoplasmic injection cycles |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Infertile patient with recurrent implantation failure. |
| Interventions | Intervention 1: Intervention group : Patients with a history of repeated implantation failure receiving Intralipid in embryo freeze transfer cycles. Intervention 2: Control group : Patients with a history of repeated implantation failure… |
| Registration date | Mar 16, 2023 |
| Target size | 70 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: